Skip to main content

Diabetes Therapy

Ausgabe 1/2024

Inhalt (21 Artikel)

Open Access Commentary

Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?

Evanthia Gouveri, Djordje S. Popovic, Nikolaos Papanas

Open Access Commentary

The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease

Jaap J. van Netten, Jan Apelqvist, Sicco A. Bus, Robert Fitridge, Fran Game, Matilde Monteiro-Soares, Eric Senneville, Nicolaas C. Schaper

Open Access Review

New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, Andrej Janez, Sanjay Kalra, Nitin Kapoor, Peter Kempler, Nader Lessan, Paulo Lotufo, Dimitri P. Mikhailidis, Luigi Nibali, Nikolaos Papanas, Tiffany Powell-Wiley, Ali A. Rizvi, Amirhossein Sahebkar, Raul D. Santos, Peter P. Toth, Vijay Viswanathan, Manfredi Rizzo

Open Access Review

Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review

Jiejin Zhu, Ying Zhou, Gang Wang

Open Access Review

Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies

Chloe H. Firman, Duane D. Mellor, David Unwin, Adrian Brown

Open Access Original Research

Is the Current Cut Point for Glycated Haemoglobin (HbA1c) Correct for Diagnosing Diabetes Mellitus in Premenopausal Women? Evidence to Inform Discussion

David Holland, Anthony A. Fryer, Mike Stedman, Fahmy W. F. Hanna, Christopher J. Duff, Lewis Green, Jonathan Scargill, Ian Halsall, Neil Gaskell, Jonathon D. Howe, Adrian H. Heald, Pensee Wu

Open Access Original Research

Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study

Takemasa Omachi, Makoto Ohara, Tomoki Fujikawa, Yo Kohata, Hiroe Sugita, Shunichiro Irie, Michishige Terasaki, Yusaku Mori, Tomoyasu Fukui, Sho-ichi Yamagishi

Open Access Original Research

Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study

Toshiki Otoda, Akiko Sekine, Ryoko Uemoto, Seijiro Tsuji, Tomoyo Hara, Motoyuki Tamaki, Tomoyuki Yuasa, Toshiaki Tamaki, Munehide Matsuhisa, Ken-ichi Aihara

Open Access Original Research

Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit Analysis

Saud Al Sifri, Raed Aldahash, Daniel-Antonio de Luis Roman, Ahmed Amin, María Camprubi-Robles, Kirk W. Kerr, Alina Juusti-Hawkes, Ariel Beresniak

Open Access Original Research

Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type 1 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation

Laura Boswell, Antonio J. Amor, Enrique Montagud-Marrahi, Gregori Casals, Daniela Díaz-Catalan, Elisenda Banon-Maneus, María José Ramírez-Bajo, Natalia Hierro, Fritz Diekmann, Mireia Musquera, Tonet Serés-Noriega, Enric Esmatjes, Joana Ferrer-Fàbrega, Pedro Ventura-Aguiar, Felicia A. Hanzu

Open Access Original Research

Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes

Aiqin He, Caifeng Shi, Xiaomei Wu, Yuting Sheng, Xueting Zhu, Junwei Yang, Yang Zhou

Open Access Original Research

A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin

Aditi Jain, Abhay Vispute, Amol Dange, Arindam Naskar, Asish Mondal, B. Vivekanand, Balram Sharma, Deepak Varade, Dhaiwat Shukla, Girish Bhatia, Harshal Chaudhari, K. Ram Babu, Onkar Gavali, Sanket Sorate, Shaishav Bhanushali, Vaibhav Kothari, Vipul Khandelwal, Akhilesh Sharma, Roshan Pawar, Mayur Mayabhate, Vinayaka Shahavi, Aashishsingh Rajput, Mukesh Jaiswal

Open Access Original Research

Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims

Yixue Shao, Lizheng Shi, Elizabeth Nauman, Eboni Price-Haywood, Charles Stoecker

Open Access Brief Report

Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study

Yasushi Ishigaki, Tetsuaki Hirase, Swathi Pathadka, Zhihong Cai, Manaka Sato, Ryo Takemura, Noriyuki Ishida

Open Access Brief Report

Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production

Umberto Capece, Chiara Pavanello, Francesca Cinti, Lucia Leccisotti, Teresa Mezza, Gea Ciccarelli, Simona Moffa, Gianfranco Di Giuseppe, Laura Soldovieri, Michela Brunetti, Alessandro Giordano, Andrea Giaccari, Laura Calabresi, Alice Ossoli

Open Access Study Protocol

Study Protocol for the Pleiotropic Effects of Sodium–Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes

Yumie Takeshita, Chiaki Nomura, Hisayoshi Murai, Yusuke Mukai, Tadayuki Hirai, Takuto Hamaoka, Shota Tokuno, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Soichiro Usui, Kenichi Nakajima, Masayuki Takamura, Toshinari Takamura

Open Access Practical Approach

The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization

Ana Chico, Jesús Moreno-Fernández, Diego Fernández-García, Eva Solá

Open Access Correction

Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review

Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, Andrej Janez, Sanjay Kalra, Nitin Kapoor, Peter Kempler, Nader Lessan, Paulo Lotufo, Dimitri P. Mikhailidis, Luigi Nibali, Nikolaos Papanas, Tiffany Powell-Wiley, Ali A. Rizvi, Amirhossein Sahebkar, Raul D. Santos, Peter P. Toth, Vijay Viswanathan, Manfredi Rizzo

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.